Owkin
@OwkinScience
Owkin uses artificial intelligence to find the right treatment for every patient.
✨ K Navigator is here! At Owkin, we believe the complexity of biology goes beyond what human intelligence can tackle alone. That’s why today we are launching K Navigator, a ground-breaking agentic co-pilot to speed up breakthroughs in biomedical research by 20x. Today, we’re…
💊 As part of our series on K Navigator research personas, meet the Drug Development Project Manager. Whether they’re juggling workstreams or translating science for teams, they’ve got it covered—all before lunch! 🔍 Do you recognize yourself in this? Tag a colleague, share your…

🚨 Calling all AI experts and computational scientists: Applications are now open for the Decoding Biology Hackathon! We’re back with a new challenge: Build agentic AI systems that can reason through complex biological questions using real-world patient data. 🧠 300k Q&A dataset…

📊 Visualize your data in seconds. K-Navigator by Owkin creates interactive plots from trusted biomedical sources like TCGA and MOSAIC-Window, no coding required. Try it free 👉 k.owkin.com/?utm_source=x&…

💡 “Biology is too complex for the human mind alone. With the right AI and the right expertise, we have a unique chance to make discoveries at scale.” Adrien Darbier, Product Expert In our latest video, Adrien shares why building K-Navigator is about more than just algorithms.…
🔥 After the incredible success of our Glioblastoma Moonshot Hackathon back in February, co-organized in partnership with @Servier, we’re doing it again. This time, we’re pushing the boundaries of AI reasoning in biology — with one of the most advanced multimodal datasets ever…

Struggling with literature reviews? K-Navigator by Owkin does the heavy lifting, summarizing biomedical literature, spotting trends, and exposing research gaps. 🧑🏼💻 Get journal-style summaries in seconds. Try it free 👉 k.owkin.com/?utm_source=x&…

Some scientists live in the literature, while others are constantly juggling clinical data, project timelines, and last-minute results. Since launching K Navigator, our agentic co-pilot for scientists, we’ve spent time with users to understand how they’re putting it to work.…

We're proud to share Owkin’s 2024 ESG & Financial Results Report. In 2024 we made strong progress on our mission to build ethical, inclusive, and sustainable AI-driven healthcare. Highlights include: 🌱 Established employee-led Green Committee and GHG emissions tracking…

Ready to prompt like a pro? K-Navigator’s strength lies in the breadth of databases it accesses and how it turns real-world data into well-reasoned scientific answers. The key is asking the right question clearly, direct, and well-phrased. Read our blog to prompt smart, not…

Digital pathology, powered by AI, is starting to play a central role in drug discovery, and biopharma is rethinking how it approaches research and development, from the early stages to clinical trials. In “Rewiring Drug Development: The Strategic Power of Pathology and AI for…

Getting nowhere with generalist LLMs? Try K-Navigator. 🧑🏼💻Literature reviews 📊Interactive data viz 📝Scientific writing 🔬Hypothesis testing Try it free 👉 k.owkin.com/?utm_source=x&…

Owkin Discovery AI: strong early results Last week, we published a blog about our Discovery AI, our multimodal model for ranking novel, clinically relevant drug targets. This week, we’re sharing new model performance study results: ✅ 16.8× better than DepMap ✅ 2.8× better…
MOSAIC just hit 2,500 samples! Thanks to our partner research hospitals across Europe and the US, MOSAIC has grown into one of the most extensive and comprehensive spatial omics datasets in cancer research. It spans 10 cancer types and 6 data modalities, including whole-tissue…
“We’re at the precipice of doing something that nobody has done before” For our new Partners in Science film, Devin Dressman, Adrian Lee, Arjun Pennathur, Maureen Lyons from @UPMC, alongside Tyler Guthrie from Owkin discuss how the MOSAIC project has the potential to be…
MSIntuit® CRC has been shortlisted for the 2025 @PrixGalien France award in the MedTech and Digital Solutions category. It's the first and only CE-marked AI diagnosticfor microsatellite instability (MSI) testing in colorectal cancer from digital H&E slides. Knowing a patient’s…

Exciting News! Our paper on MixupVI, a deep generative model for cell-type deconvolution has been accepted for presentation at ICML 2025! Join us in Vancouver on Friday, July 18th, for our poster session with Simon Grouard 🔬 MixupVI enables robust, reference-free deconvolution…
💡 How far have we come with AI-driven target discovery? How far do we have yet to go? Read our new blog to find out. Over the past decade, a wave of AI-first biotech companies has emerged to disrupt the status quo - each with its own approach. This blog unpacks how AI can work…
Our co-founder and CEO @TClozel is speaking at the @RaiseSummit in Paris tomorrow! He’ll be on stage at 6pm to share his vision for biological superintelligence (BASI), and how we use patient data and AI to decode biology and solve medicine’s hardest problems. He’s joining an…
